Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: outcomes of clinical trials in sepsis: lessons learned.
Vincent
J L
JL
Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium.
Angus
D
D
Annane
D
D
Bernard
G
G
Faist
E
E
Giroir
B
B
Reinhart
K
K
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000382:microbiology; D003422:Critical Care / Q000379:methods / Q000592:standards / Q000639:trends; D006801:Humans; D007249:Inflammation; D008074:Lipoproteins / Q000627:therapeutic use; D009017:Morbidity; D011486:Protein C / Q000502:physiology / Q000627:therapeutic use; D012107:Research Design; D018805:Sepsis / Q000150:complications / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D012720:Severity of Illness Index; D013256:Steroids; D016019:Survival Analysis; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D008074:Lipoproteins; D011486:Protein C; D013256:Steroids; C051928:lipoprotein-associated coagulation inhibitor